Cargando…
Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention
Congenital anomalies may have an increased risk of noncommunicable diseases (NCDs) We performed a clinical exome analysis in an infant affected by “Vertebral, Anorectal, Cardiac, Tracheoesophageal, Genitourinary, and Limb” (VACTERL) malformation association to identify potential biomarkers that may...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838983/ https://www.ncbi.nlm.nih.gov/pubmed/33466296 http://dx.doi.org/10.3390/pediatric13010006 |
_version_ | 1783643305383297024 |
---|---|
author | Pelizzo, Gloria Chiricosta, Luigi Mazzon, Emanuela Zuccotti, Gian Vincenzo Avanzini, Maria Antonietta Croce, Stefania Lima, Mario Bramanti, Placido Calcaterra, Valeria |
author_facet | Pelizzo, Gloria Chiricosta, Luigi Mazzon, Emanuela Zuccotti, Gian Vincenzo Avanzini, Maria Antonietta Croce, Stefania Lima, Mario Bramanti, Placido Calcaterra, Valeria |
author_sort | Pelizzo, Gloria |
collection | PubMed |
description | Congenital anomalies may have an increased risk of noncommunicable diseases (NCDs) We performed a clinical exome analysis in an infant affected by “Vertebral, Anorectal, Cardiac, Tracheoesophageal, Genitourinary, and Limb” (VACTERL) malformation association to identify potential biomarkers that may be helpful for preventing malignancy risk or other chronic processes. Among the variants, six variants that may be linked with VACTERL were identified in the exome analysis. The variants c.501G>C on OLR1 and c.-8C>G on PSMA6 were previously associated with myocardial infarction. The variants c.1936A>G on AKAP10 and c.575A>G on PON1 are linked to defects in cardiac conduction and artery disease, respectively. Alterations in metabolism were also suggested by the variants c.860G>A on EPHX2 and c.214C>A on GHRL. In addition, three variants associated with colon cancer were discovered. Specifically, the reported variants were c.723G>A on CCND1 and c.91T>A on AURKA proto-oncogenes as well as c.827A>C in the tumor suppressor PTPRJ. A further inspection identified 15 rare variants carried by cancer genes. Specifically, these mutations are located on five tumor suppressors (SDHA, RB1CC1, PTCH1, DMBT1, BCR) and eight proto-oncogenes (MERTK, CSF1R, MYB, ROS1, PCM1, FGFR2, MYH11, BRCC3) and have an allele frequency lower than 0.01 in the Genome Aggregation Database (GnomAD). We observed that the cardiac and metabolic phenotypic traits are linked with the genotype of the patient. In addition, the risk of developing neoplasia cannot be excluded a priori. Long-term surgical issues of patients with VATER syndrome could benefit from the clinical exome sequencing of a personalized risk assessment for the appearance of further disease in pubertal timing and adult age. |
format | Online Article Text |
id | pubmed-7838983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78389832021-01-28 Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention Pelizzo, Gloria Chiricosta, Luigi Mazzon, Emanuela Zuccotti, Gian Vincenzo Avanzini, Maria Antonietta Croce, Stefania Lima, Mario Bramanti, Placido Calcaterra, Valeria Pediatr Rep Case Report Congenital anomalies may have an increased risk of noncommunicable diseases (NCDs) We performed a clinical exome analysis in an infant affected by “Vertebral, Anorectal, Cardiac, Tracheoesophageal, Genitourinary, and Limb” (VACTERL) malformation association to identify potential biomarkers that may be helpful for preventing malignancy risk or other chronic processes. Among the variants, six variants that may be linked with VACTERL were identified in the exome analysis. The variants c.501G>C on OLR1 and c.-8C>G on PSMA6 were previously associated with myocardial infarction. The variants c.1936A>G on AKAP10 and c.575A>G on PON1 are linked to defects in cardiac conduction and artery disease, respectively. Alterations in metabolism were also suggested by the variants c.860G>A on EPHX2 and c.214C>A on GHRL. In addition, three variants associated with colon cancer were discovered. Specifically, the reported variants were c.723G>A on CCND1 and c.91T>A on AURKA proto-oncogenes as well as c.827A>C in the tumor suppressor PTPRJ. A further inspection identified 15 rare variants carried by cancer genes. Specifically, these mutations are located on five tumor suppressors (SDHA, RB1CC1, PTCH1, DMBT1, BCR) and eight proto-oncogenes (MERTK, CSF1R, MYB, ROS1, PCM1, FGFR2, MYH11, BRCC3) and have an allele frequency lower than 0.01 in the Genome Aggregation Database (GnomAD). We observed that the cardiac and metabolic phenotypic traits are linked with the genotype of the patient. In addition, the risk of developing neoplasia cannot be excluded a priori. Long-term surgical issues of patients with VATER syndrome could benefit from the clinical exome sequencing of a personalized risk assessment for the appearance of further disease in pubertal timing and adult age. MDPI 2021-01-05 /pmc/articles/PMC7838983/ /pubmed/33466296 http://dx.doi.org/10.3390/pediatric13010006 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Pelizzo, Gloria Chiricosta, Luigi Mazzon, Emanuela Zuccotti, Gian Vincenzo Avanzini, Maria Antonietta Croce, Stefania Lima, Mario Bramanti, Placido Calcaterra, Valeria Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title | Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title_full | Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title_fullStr | Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title_full_unstemmed | Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title_short | Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention |
title_sort | discovering genotype variants in an infant with vacterl through clinical exome sequencing: a support for personalized risk assessment and disease prevention |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838983/ https://www.ncbi.nlm.nih.gov/pubmed/33466296 http://dx.doi.org/10.3390/pediatric13010006 |
work_keys_str_mv | AT pelizzogloria discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT chiricostaluigi discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT mazzonemanuela discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT zuccottigianvincenzo discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT avanzinimariaantonietta discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT crocestefania discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT limamario discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT bramantiplacido discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention AT calcaterravaleria discoveringgenotypevariantsinaninfantwithvacterlthroughclinicalexomesequencingasupportforpersonalizedriskassessmentanddiseaseprevention |